Peptides/Retatrutide
Retatrutide
Metabolicstrong evidence

Retatrutide

A first-in-class triple hormone receptor agonist (GLP-1/GIP/glucagon) that achieved up to 24.2% weight reduction in phase 2 clinical trials.

Retatrutide (LY3437943) is an investigational once-weekly injectable peptide developed by Eli Lilly that simultaneously activates three metabolic hormone receptors: GLP-1, GIP, and glucagon. In a landmark phase 2 trial published in the New England Journal of Medicine, the 12 mg dose achieved 24.2% mean body weight reduction at 48 weeks, with 100% of participants losing at least 5% of their body weight. It also demonstrated remarkable liver fat reduction of up to 82%.

⚙️ Mechanism of Action

Retatrutide simultaneously engages three receptor pathways: GLP-1 receptor activation reduces appetite and slows gastric emptying; GIP receptor activation enhances insulin secretion and may amplify GLP-1 effects on weight; glucagon receptor activation increases hepatic energy expenditure and fat oxidation. This triple agonism creates synergistic metabolic effects that exceed those of dual-agonist therapies, particularly in driving energy expenditure and reducing liver fat.

Benefits

  • Up to 24.2% body weight reduction at 48 weeks in trials
  • Reduces liver fat by up to 82%
  • Improves HbA1c by up to 2.2% in type 2 diabetes
  • Once-weekly dosing convenience
  • Superior weight loss compared to dual-agonist approaches
  • 100% of participants achieved clinically meaningful weight loss at highest dose

⚠️ Risks & Considerations

  • Nausea and vomiting (most common, usually transient)
  • Diarrhea and constipation
  • Decreased appetite
  • Injection site reactions
  • Potential gallbladder events (under investigation)

Ready to Start?

$59.99 – $249.99

Purchase research-grade Retatrutide from a trusted supplier.

Purchase Retatrutide

Affiliate link — we may earn a commission at no extra cost to you.

Quick Facts

💉
Dosing Range
1-12 mg weekly subcutaneously (titrated)
⏱️
Half-Life
~6 days
🔄
Typical Cycle
Consult protocol guidelines
Time to Effect
Varies by individual
Administration Routes
Subcutaneous injection
🧬PeptidesAgent

⚠️ For informational purposes only. Not medical advice. Always consult a qualified healthcare provider before using any peptide or supplement.

© 2026 PeptidesAgent·Admin

PeptidesAgent

Usually replies instantly

Hi there! 👋

Ask me anything about peptides, dosing protocols, or stacks.

For research purposes only · Not medical advice